Episode Details

Back to Episodes
Discussing AxSpA: Long-term etanercept response & real-world effectiveness of tofacitinib & adalimumab

Discussing AxSpA: Long-term etanercept response & real-world effectiveness of tofacitinib & adalimumab

Published 1 year, 9 months ago
Description
Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar and Xenofon Baraliakos to discuss the long-term etanercept response in patients with radiographic axSpA and the comparison of tofacitinib and adalimumab in a real-world clinical context.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us